A joint statement sent to President Obama by America's leading national non-profit Turkish and Turkic organizations. The statement says: ''Wartime tradegy suffered by all peoples, not just Armenians.'' Armenian terrorism, revolts, and treason triggering this tragedy still not acknowledged. The statement is signed by Ergun Kirlikovali, ATAA President, Ali Cinar , FTAA President, Adem Buyukacar, TACC Secretary General, Tomris Azeri, ASA President, Javid Huseynov, Ph.D., AAC General Director. The statement is as below:
Coca-Cola is offering shareholders a two-for-one split for their stock. Chief Executive Officer Muhtar Kent announced the recommendation Wednesday at the company's annual shareholder meeting at the Cobb Galleria, eliciting a rousing round of applause from the roughly 600 people gathered. Kent said the share split would be the 11th in the 92-year history of the company's stock and the first time the company offered the split since 1996.
By Marthe Fourcade - Amgen Inc. (AMGN), the world’s largest biotechnology company, agreed to buy closely held Mustafa Nevzat Pharmaceuticals for almost $700 million to expand in Turkey, where economic growth is boosting demand for medicines. Amgen will pay cash to get 95.6 percent of Mustafa Nevzat, or MN Pharmaceuticals as the Istanbul-based generic-drug maker is known, the companies said in a joint statement. The transaction will boost Amgen’s presence in a region that has “large, fast-growing, priority markets,” they said.
Following the world's richest businessman Carlos Slim, another Ottoman descendent is planning to come to Turkey. Brazilian millionaire Joseph Safra, whose ancestors used to trade in Istanbul, has supposedly now set his sights on Turkey. Turkey, which has fast become a highly desirable destination for both European and Asian investors, has now piqued the interest of Latin Americans. After Carlos Slim, the world's richest businessman with a fortune worth 69 billion dollars, another Lebanese-rooted Ottoman descendent is seeking out investments in Turkey. 
